Update: Neumora's IPO went effective March 26, 2025 (NasdaqGS:NMRA).
A PRELIMINARY IPO filing yesterday by Massachusetts-based Neumora Therapeutics lists among company advanta.... Read More
During last week's venture-capital panel discussion here in Nashville, the Most Sobering Comment Award probably went to Sid Chambless, the executive director of Nashville Capi.... Read More
Tennessee Technology Development Corporation yesterday reported further progress in stitching-together the state's science and technology stakeholders.
The TTDC board of direc.... Read More